Evaluating the Newly Proposed ARDS Definition in Hospitalized Patients With COVID-19 Treated With High-Flow Nasal Oxygen

被引:1
作者
Isha, Shahin [1 ]
Olaizola, Gustavo [2 ,3 ]
Bisso, Indalecio Carboni [2 ]
Raavi, Lekhya [1 ]
Jonna, Sadhana [1 ]
Jenkins, Anna [1 ]
Hanson, Abby [1 ]
Kashyap, Rahul [1 ,4 ]
Monzon, Veronica [5 ]
Huespe, Ivan A. [2 ,3 ]
Sanghavi, Devang [1 ]
机构
[1] Mayo Clin, Jacksonville, FL USA
[2] Hosp Italiano Buenos Aires, Buenos Aires, Argentina
[3] Univ Buenos Aires, Buenos Aires, Argentina
[4] Well Span Hlth, York, PA USA
[5] Hosp Italiano Agustin Roca, Buenos Aires, Argentina
关键词
ARDS; coronavirus disease 2019; high-flow nasal cannula oxygen; oxygen saturation; critical care; RESPIRATORY-DISTRESS-SYNDROME;
D O I
10.4187/respcare.11933
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: The new Global definition of ARDS recently introduced a subgroup known as non-intubated ARDS. This study aimed to assess the risk of progression from noninvasive oxygen support to intubation and ARDS severity based on the S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> among non-intubated subjects with ARDS. Methods: This retrospective study included subjects with COVID-19 admitted to 7 hospitals (5 in the United States and 2 in Argentina) from January 2020-January 2023. Subjects meeting the new non-intubated ARDS definition (high-flow nasal cannula [HFNC] with an S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> <= 315 [with S<INF>pO<INF>2</INF></INF> <= 97%] or a P<INF>aO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> <= 300 mm Hg while receiving >= 30 L/min O<INF>2</INF> via HFNC) were included. The study evaluated the proportion of subjects who progressed to intubation, severity levels using the S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> cutoff proposed in the new ARDS definition, and mortality. Results: Nine hundred sixty-five non-intubated subjects with ARDS were included, of whom 27% (n = 262) progressed to meet the Berlin criteria within a median of 3 d (interquartile range 2-6). The overall mortality was 23% (95% CI 20-26) (n = 225), and among subjects who progressed to the Berlin criteria, it was 37% (95% CI 31-43) (n = 98). Additionally, the worst S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> within 1 d of ARDS diagnosis was correlated with mortality, with mortality rates of 26% (95% CI 23-30) (n = 177) for subjects with S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> <= 148, 17% (95% CI 12-23) (n = 38) for those with S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> between 149-234, and 16% (95% CI 8-28) (n = 10) for subjects maintaining an S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> higher than 235 (P < .001). Conclusions: The non-intubated ARDS criteria encompassed a broader spectrum of subjects with lower in-hospital mortality compared to the Berlin criteria. The S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> and ARDS severity cutoff proposed in the new Global ARDS definition were valuable predictors of in-hospital mortality in these subjects.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 50 条
  • [21] Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey
    Tzotzos, Susan J.
    Fischer, Bernhard
    Fischer, Hendrik
    Zeitlinger, Markus
    CRITICAL CARE, 2020, 24 (01):
  • [22] High flow nasal cannula to prevent intubation in obese patient with COVID-19 induced ARDS: a case report
    Mariati, Ni Made Ayu Suria
    Sugiarto, Adhrie
    Endriani, Elya
    Lestari, Rina
    Anindita, Karina
    ANAESTHESIA PAIN & INTENSIVE CARE, 2021, 25 (02) : 212 - 216
  • [23] Impact of Body Mass Index on the Use of Prone Vigil and High-Flow Nasal Cannula in Pattients with COVID-19
    Baeza Canales, Ricardo
    Leiva Arrue, Miryam
    Montecino Sepulveda, Maria
    Valenzuela Vasquez, Jorge
    Godoy Abarca, Loretto
    Gonzalez Concha, Nicole
    Munoz-Cofre, Rodrigo
    del Sol, Mariano
    Escobar-Cabello, Maximo
    INTERNATIONAL JOURNAL OF MORPHOLOGY, 2022, 40 (04): : 1088 - 1093
  • [24] Physiologic Effects of the Awake Prone Position Combined With High-Flow Nasal Oxygen on Gas Exchange and Work of Breathing in Patients With Severe COVID-19 Pneumonia: A Randomized Crossover Trial
    Lehingue, Samuel
    Allardet-Servent, Jerome
    Ferdani, Anne
    Hraeich, Sami
    Forel, Jean-Marie
    Arnal, Jean-Michel
    Prud'homme, Eloi
    Penaranda, Guillaume
    Bourenne, Jeremy
    Monnet, Olivier
    Gainnier, Marc
    Cantais, Emmanuel
    CRITICAL CARE EXPLORATIONS, 2022, 4 (12) : E0805
  • [25] High flow nasal cannula in COVID-19: a literature review
    Gurun Kaya, Aslihan
    Oz, Mirac
    Erol, Serhat
    Ciftci, Fatma
    Ciledag, Aydin
    Kaya, Akin
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2020, 68 (02): : 168 - 174
  • [26] High-flow nasal cannula therapy in a predominantly African American population with COVID-19 associated acute respiratory failure
    Nguyen, Paul L.
    Osman, Heba
    Watza, Donovan
    Khicher, Suman
    Sharma, Aditi
    Dyson, Greg
    Saydain, Ghulam
    Soubani, Ayman
    BMJ OPEN RESPIRATORY RESEARCH, 2021, 8 (01)
  • [27] Factors associated with intubation in patients with acute hypoxaemic respiratory failure treated with high-flow nasal cannula oxygen therapy: A prospective, observational study
    Weir, Timothy E.
    Bihari, Shailesh
    AUSTRALIAN CRITICAL CARE, 2024, 37 (03) : 455 - 460
  • [28] High-flow nasal cannula oxygen therapy in critical patients. Prospective study
    Velasco Sanz, T. R.
    Sanchez de la Ventana, A. B.
    ENFERMERIA INTENSIVA, 2014, 25 (04): : 131 - 136
  • [29] Vaccination protects against acute respiratory distress syndrome (ARDS) in hospitalized patients with COVID-19
    Madrid, Julian
    Agarwal, Prerana
    Mueller-Peltzer, Katharina
    Askani, Marvin
    Benning, Leo
    Selig, Mischa
    Diehl, Philipp
    Kalbhenn, Johannes
    Trummer, Georg
    Utzolino, Stefan
    Wengenmayer, Tobias
    Busch, Hans-Joerg
    Stolz, Daiana
    Rieg, Siegbert
    Panning, Marcus
    Schlett, Christopher L.
    Bamberg, Fabian
    Askani, Esther
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [30] Comparison of Hospitalized Patients With ARDS Caused by COVID-19 and H1N1
    Tang, Xiao
    Du, Rong-Hui
    Wang, Rui
    Cao, Tan-Ze
    Guan, Lu-Lu
    Yang, Cheng-Qing
    Zhu, Qi
    Hu, Ming
    Li, Xu-Yan
    Li, Ying
    Liang, Li-Rong
    Tong, Zhao-Hui
    Sun, Bing
    Peng, Peng
    Shi, Huan-Zhong
    CHEST, 2020, 158 (01) : 195 - 205